Literature DB >> 23512700

Pure ocular anti-musk myasthenia under no immunosuppressive treatment.

Vasiliki Zouvelou1, Athanasios Papathanasiou, Christos Koros, Michael Rentzos, Thomas Zambelis, Eleftherios Stamboulis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23512700     DOI： 10.1002/mus.23847

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


× No keyword cloud information.
  4 in total

Review 1.  Anti-MuSK ocular myasthenia with extrinsic ocular muscle atrophy: a new clinical phenotype?

Authors:  Dario Ricciardi; Vincenzo Todisco; Gioacchino Tedeschi; Giovanni Cirillo
Journal:  Neurol Sci       Date:  2019-08-17       Impact factor: 3.307

2.  Ocular myasthenia gravis: controversies and updates.

Authors:  Sui H Wong; Saif Huda; Angela Vincent; Gordon T Plant
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

Review 3.  Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management.

Authors:  Konstantinos Lazaridis; Socrates J Tzartos
Journal:  Front Neurol       Date:  2020-11-30       Impact factor: 4.003

Review 4.  Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics.

Authors:  Konstantinos Lazaridis; Socrates J Tzartos
Journal:  Front Immunol       Date:  2020-02-14       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.